Sensitivity to fadraciclib was increased in AML and ALL cell lines carrying MLLr/MLL-PTD (Fig 4A and 4B, S2 Fig and S7 Table), and this may be due to dependence on the MLL-mediated transcription of HOXA9/MEIS1. The gene discussed is MEIS1; the disease is acute myeloid leukemia.